Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lorna Layward"'
Autor:
Anne Rigby, Sandrine Vessillier, David Baker, Gill Adams, Lorna Layward, Lisa Mullen, Alex Annenkov, Gayatri Mittal, Michelle Sclanders, Yuti Chernajovsky, David Gould
Publikováno v:
Expert Opinion on Drug Delivery. 11:101-110
The use of cytokines as therapeutic agents is important, given their potent biological effects. However, this very potency, coupled with the pleiotropic nature and short half-life of these molecules, has limited their therapeutic use. Strategies to i
Autor:
Gill Adams, Mario Köster, Sandrine Vessillier, Hansjörg Hauser, Julie Foster, Lorna Layward, Yuti Chernajovsky, David Gould, Lisa Mullen
Publikováno v:
Annals of the Rheumatic Diseases. 73:1728-1736
Background Latent cytokines are engineered by fusing the latency associated peptide (LAP) derived from transforming growth factor-β (TGF-β) with the therapeutic cytokine, in this case interferon-β (IFN-β), via an inflammation-specific matrix meta
Autor:
Lorna Layward, Pamela Holmes
Publikováno v:
British Journal of Community Nursing. 11:433-436
In this article, brought to you in association with Help the Aged, the authors discuss current research into the causes and management of urinary incontinence.
Publikováno v:
Clinical and Experimental Immunology. 122:445-452
SUMMARYPolyunsaturated fatty acids are known to affect the immune response and administration of the omega-6 fatty acid linoleic acid has been reported to be beneficial in multiple sclerosis (MS) and EAE. In this study we have investigated the effect
Publikováno v:
Immunology Today. 18:368-371
Correlation of the heterogeneic immunopathological profiles of multiple sclerosis (MS) lesions with the paraclinical and clinical markers of disease may be important in the development of therapeutic approaches in MS. This and other issues were discu
Autor:
Gayatri Mittal, Lorna Layward, Sarah Al-Izki, Rewas Fatah, David Baker, Gill Adams, Alex Annenkov, Sandrine Vessillier, Chris Bolton, Yuti Chernajovsky, Julie Foster, Anne Rigby, Gareth Pryce, Hansjörg Hauser, Cristina Subang, Lisa Mullen, David Gould, Julia M Colston, Michelle Sclanders, Philippa Francis-West, Mario Köster
Publikováno v:
Expert opinion on drug delivery. 11(1)
Targeting cytokines to sites of disease has clear advantages because it increases their therapeutic index. We designed fusion proteins of the latent-associated peptide (LAP) derived from TGF-β with various cytokines via a matrix metalloproteinase (M
Publikováno v:
Amor, S, Layward, L & Van Noort, J M 1998, ' Multiple sclerosis : Modelling the future ', Molecular Medicine Today, vol. 4, no. 8, pp. 328-330 . https://doi.org/10.1016/S1357-4310(98)01305-7
Molecular Medicine Today, 4(8), 328-330. Elsevier BV
Molecular Medicine Today, 4(8), 328-330. Elsevier BV
The Multiple Sclerosis Society of Great Britain and Northern Ireland Conference: Frontiers in Science and Patient Care Disease Management Birmingham, UK, 5–6 May 1998
Publikováno v:
BMJ (Clinical research ed.). 332(7534)
Although gene therapy has huge potential for modern medicine, our enthusiasm for its powerful potential must not cloud our judgment about the dangers of using increasingly diverse, yet relatively untested, replicating viruses
Autor:
Lorna Layward
Publikováno v:
Current biology : CB. 8(2)
There has been a quiet revolution in UK medical charities over the past two decades. Increasing competition for donations, adoption of new roles relative to the state and private sectors, and the requirement for more accountability have all played th
Publikováno v:
Biochemical Society transactions. 25(2)
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune and demyelinating disease of the central nervous system (CNS) inducible in susceptible rodents and other mammalian species by active or adoptive sensitization to CNS constituents [I]. E